Anti–Cyclic Citrullinated Peptide Antibodies in Advanced Rheumatoid Arthritis

  1. Geraldo Castelar Pinheiro, MD;
  2. Morton A. Scheinberg, MD, PhD;
  3. Miriam Aparecida da Silva, BS; and
  4. Suely Maciel, BS
  1. Universidade Estadual do Rio de Janeiro; Rio de Janeiro, Brazil (Castelar, Pinheiro) Hospital Israelita Albert Einstein; Sao Paulo, Brazil (Scheinberg) L.I.D. Laboratory; Sao Paulo, Brazil (Aparecida da Silva, Maciel)

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR: …

    « Previous | Next Article »Table of Contents